Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Mise à jour : Il y a 4 ans
Référence : NCT00135356

Femme et Homme

Extrait

The purpose of this clinical research study is to learn if human immunodeficiency virus (HIV)-infected subjects with abdominal fat accumulation on their highly active antiretroviral treatment (HAART) regimen have better changes in fat distribution after switching to atazanavir-ritonavir than those remaining on their current protease inhibitor boosted HAART regimen.


Critère d'inclusion

  • HIV-Associated Lipodystrophy Syndrome


Liens